$206,00
-$2,50(-1,19 %)
*Data last updated: 2026-07-11 06:40 (UTC+8)
As of 2026-07-11 06:40, IQVIA Holdings Inc (IQV) is priced at $206,00, with a total market cap of $32,24B, a P/E ratio of 28,49, and a dividend yield of 0,00 %. Today, the stock price fluctuated between $184,10 and $214,62. The current price is 11,89 % above the day's low and 4,01 % below the day's high, with a trading volume of 1,01M. Over the past 52 weeks, IQV has traded between $141,20 to $220,88, and the current price is -6,73 % away from the 52-week high.
IQV Key Stats
Yesterday's Close$193,28
Market Cap$32,24B
Volumen1,01M
P/E Ratio28,49
Dividend Yield (TTM)0,00 %
Diluted EPS (TTM)8,22
Net Income (FY)$1,36B
Revenue (FY)$16,31B
Earnings Date2026-07-28
EPS Estimate3,03
Revenue Estimate$4,30B
Shares Outstanding166,84M
Beta (1Y)1.215
About IQV
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOAri Bousbib
HeadquartersDurham,NC,US
Official Websitehttps://www.iqvia.com
Employees (FY)93,00K
Average Revenue (1Y)$175,37K
Net Income per Employee$14,62K
IQVIA Holdings Inc (IQV) FAQ
What's the stock price of IQVIA Holdings Inc (IQV) today?
x
IQVIA Holdings Inc (IQV) is currently trading at $206,00, with a 24h change of -1,19 %. The 52-week trading range is $141,20–$220,88.
What are the 52-week high and low prices for IQVIA Holdings Inc (IQV)?
x
What is the price-to-earnings (P/E) ratio of IQVIA Holdings Inc (IQV)? What does it indicate?
x
What is the market cap of IQVIA Holdings Inc (IQV)?
x
What is the most recent quarterly earnings per share (EPS) for IQVIA Holdings Inc (IQV)?
x
Should you buy or sell IQVIA Holdings Inc (IQV) now?
x
What factors can affect the stock price of IQVIA Holdings Inc (IQV)?
x
How to buy IQVIA Holdings Inc (IQV) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.